Army Department November 6, 2009 – Federal Register Recent Federal Regulation Documents
Results 1 - 6 of 6
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Methods and Composition for Live Bubonic Plague Vaccine Based on Yersinia Pestis * * * Gene Deletion
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/242,113 entitled ``Methods and Composition for Live Bubonic Plague Vaccine Based On Yersinia Pestis * * * Gene Deletion,'' filed September 14, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Enhanced Substrates for the Protease Activity of Serotype a Botulinum Neurotoxin
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/252,675 entitled ``Enhanced Substrates for the Protease Activity of Serotype a Botulinum Neurotoxin,'' filed October 18, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Inland Waterways Users Board
In accordance with 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), announcement is made of the forthcoming meeting.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
